<!--DEBUG:--><!--DEBUG:dc3-united-states-science-in-english-pdf--><!--DEBUG:--><!--DEBUG:dc3-united-states-science-in-english-pdf--><!--DEBUG-spv-->{"id":1996410,"date":"2021-09-25T00:06:00","date_gmt":"2021-09-24T22:06:00","guid":{"rendered":"http:\/\/nhub.news\/?p=1996410"},"modified":"2021-09-25T04:42:11","modified_gmt":"2021-09-25T02:42:11","slug":"covid-19-booster-shots-now-available-at-select-cvs-pharmacies","status":"publish","type":"post","link":"http:\/\/nhub.news\/fr\/2021\/09\/covid-19-booster-shots-now-available-at-select-cvs-pharmacies\/","title":{"rendered":"COVID-19 Booster Shots Now Available At Select CVS Pharmacies"},"content":{"rendered":"<p style=\"text-align: justify;\"><b>CVS Health announced Friday that select CVS Pharmacy locations are now offering the Pfizer-BioNTech COVID-19 booster shot to eligible populations.<\/b><br \/>\nMIAMI (CBSMiami) \u2013 CVS Health announced Friday that select CVS Pharmacy locations are now offering the Pfizer-BioNTech COVID-19 booster shot to eligible populations. CVS announced they would be following the following CDC guidelines: \u2022 People 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer-BioNTech\u2019s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series \u2022 People aged 50 to 64 with certain underlying medical conditions should receive a booster shot of Pfizer-BioNTech\u2019s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series \u2022 People 18 to 49 who are at high risk for severe COVID-19 due to certain underlying medical conditions may receive a booster shot of Pfizer-BioNTech\u2019s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series, based on their individual benefits and risk \u2022 People aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting may receive a booster shot of Pfizer-BioNTech\u2019s COVID-19 vaccine at least 6 months after their Pfizer-BioNTech primary series The chain said individuals who initially received the Moderna or Johnson &amp; Johnson (Janssen) COVID-19 vaccine are not eligible for a booster at this time, per guidance from the public health agencies. \u201cWe have the experience and the infrastructure to play a leading role in administering booster shots to eligible populations,\u201d said Troyen A. Brennan, M.D., MPH, Executive Vice President and Chief Medical Officer of CVS Health. \u201cWe also continue to make it as convenient as possible for the unvaccinated to receive their first doses.\u201d Those interested in receiving the Pfizer-BioNTech COVID-19 booster or their initial vaccine series are strongly encouraged to make an appointment at CVS.com.<\/p>\n<script>jQuery(function(){jQuery(\".vc_icon_element-icon\").css(\"top\", \"0px\");});<\/script><script>jQuery(function(){jQuery(\"#td_post_ranks\").css(\"height\", \"10px\");});<\/script><script>jQuery(function(){jQuery(\".td-post-content\").find(\"p\").find(\"img\").hide();});<\/script>","protected":false},"excerpt":{"rendered":"<p>CVS Health announced Friday that select CVS Pharmacy locations are now offering the Pfizer-BioNTech COVID-19 booster shot to eligible populations. MIAMI (CBSMiami) \u2013 CVS Health announced Friday that select CVS Pharmacy locations are now offering the Pfizer-BioNTech COVID-19 booster shot to eligible populations. CVS announced they would be following the following CDC guidelines: \u2022 People [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1996409,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[113],"tags":[],"_links":{"self":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts\/1996410"}],"collection":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/comments?post=1996410"}],"version-history":[{"count":1,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts\/1996410\/revisions"}],"predecessor-version":[{"id":1996411,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts\/1996410\/revisions\/1996411"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/media\/1996409"}],"wp:attachment":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/media?parent=1996410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/categories?post=1996410"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/tags?post=1996410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}